Question: why zantac ban in pakistan?
Answer: In greater public interest and in order to protect patients from risk associated with detection of low levels of NDMA in ranitidine containing products as per alert of FDA and EMA, the DRAP at first advised to halt the distribution/sale/utilization of ranitidine containing medicines in Pakistan followed by its recall ...